A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)
Ascendis Pharma Endocrinology Division A/S
Summary
The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care
Description
Patients will be treated according to routine clinical practice, and no additional visits, examinations or tests will be required beyond those performed as part of routine clinical practice except for COAs.
Eligibility
- Age range
- Not specified
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Patients who are on treatment with SKYTROFA (lonapegsomatropin) * Patients being clinically managed in USA * Patients with an appropriate written informed consent/assent as applicable for the age of the patient Exclusion Criteria: * Patients participating in any interventional clinical study
Interventions
- OtherNo intervention
No intervention
Locations (27)
- Ascendis Investigational SitePhoenix, Arizona
- Ascendis Investigational SiteOrange, California
- Ascendis Investigational SiteSacramento, California
- Ascendis Investigational SiteSan Francisco, California
- Ascendis Pharma Investigational SiteCentennial, Colorado
- Ascendis Investigational SiteWashington D.C., District of Columbia